Word

CIR

Status

Pending

Status Code

688

Status Date

Tuesday, June 25, 2024

Serial Number

98088355

Mark Type

4

Filing Date

Monday, July 17, 2023

Published for Opposition

Tuesday, April 30, 2024

Trademark Owner History

NKILT Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations, in particular in the form of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; living cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; biological preparations in the form of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; therapeutic pharmaceuticals utilizing cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages in the treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections; cell preparations such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for treatment of immune-oncological disorders, cancer, hyperproliferative diseases, and infections

1 Chemical and biochemical preparations for scientific purposes, in particular in the form of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages for laboratory and experimentation purposes, in particular for conducting experimental assays, other than for medical or veterinary purposes; reagents for scientific and research use, namely, reagents such as proteins and nucleic acids for modifying cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages

44 Medical services, in particular in the field of immunotherapy, in particular in the field of immuno-oncology; medical services in the field of hyperproliferative diseases; medical services in the field of cancer; medical services in the field of anti-infectives; in particular all of the aforesaid services related to the use of protein, nucleic acid, or cells such as T cells, NK cells, NKT cells, iNKT cells, or macrophages

42 Scientific and technological services, namely, scientific research, analysis and testing in the field of biology, pharmaceuticals and cell therapy; biological research and development; medical, pharmaceutical and biotechnological research

Trademark Events

Jul 20, 2023

New Application Entered

Aug 15, 2023

New Application Office Supplied Data Entered

Mar 22, 2024

Assigned To Examiner

Mar 25, 2024

Approved For Pub - Principal Register

Apr 10, 2024

Notification Of Notice Of Publication E-Mailed

Jun 25, 2024

Noa E-Mailed - Sou Required From Applicant

Apr 30, 2024

Published For Opposition

Apr 30, 2024

Official Gazette Publication Confirmation E-Mailed